- Report
- July 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- October 2024
- 194 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- January 2022
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 119 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2021
- 270 Pages
Global
From €2386EUR$2,500USD£1,999GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more